Blue Capital Reinsurance (NYSE:BCRH) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday.
According to Zacks, “Blue Capital Holdings Ltd. is a reinsurance holding company. It offers collateralized reinsurance in the property catastrophe market. Blue Capital Holdings Ltd. is based in Bermuda. “
A number of other equities analysts have also recently issued reports on BCRH. ValuEngine upgraded Blue Capital Reinsurance from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Raymond James Financial restated an “underperform” rating on shares of Blue Capital Reinsurance in a report on Friday, October 13th. Deutsche Bank cut Blue Capital Reinsurance from a “buy” rating to a “hold” rating and reduced their target price for the stock from $21.00 to $18.00 in a report on Monday, October 16th. TheStreet cut Blue Capital Reinsurance from a “b-” rating to a “c+” rating in a report on Friday, October 27th. Finally, Jefferies Group cut Blue Capital Reinsurance to a “hold” rating in a report on Wednesday, November 29th. One analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $18.00.
Shares of Blue Capital Reinsurance (NYSE BCRH) traded up $0.10 on Wednesday, reaching $12.35. The company’s stock had a trading volume of 30,808 shares, compared to its average volume of 46,401. Blue Capital Reinsurance has a 12-month low of $11.70 and a 12-month high of $20.83. The company has a market capitalization of $108.20, a PE ratio of -2.76 and a beta of -0.05.
Blue Capital Reinsurance (NYSE:BCRH) last issued its earnings results on Monday, October 30th. The insurance provider reported ($5.93) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($5.89) by ($0.04). Blue Capital Reinsurance had a negative return on equity of 23.35% and a negative net margin of 77.93%. The company had revenue of $19.10 million for the quarter, compared to the consensus estimate of $12.31 million. During the same quarter last year, the business posted $0.38 EPS. Blue Capital Reinsurance’s quarterly revenue was up 92.9% on a year-over-year basis. sell-side analysts anticipate that Blue Capital Reinsurance will post -4.4 earnings per share for the current year.
A number of institutional investors and hedge funds have recently modified their holdings of the business. Aberdeen Asset Management PLC UK lifted its holdings in shares of Blue Capital Reinsurance by 17.6% during the 2nd quarter. Aberdeen Asset Management PLC UK now owns 457,513 shares of the insurance provider’s stock valued at $8,372,000 after purchasing an additional 68,414 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Blue Capital Reinsurance by 1.6% during the 2nd quarter. Vanguard Group Inc. now owns 181,100 shares of the insurance provider’s stock valued at $3,315,000 after purchasing an additional 2,803 shares in the last quarter. Royce & Associates LP lifted its holdings in shares of Blue Capital Reinsurance by 40.0% during the 3rd quarter. Royce & Associates LP now owns 161,392 shares of the insurance provider’s stock valued at $2,655,000 after purchasing an additional 46,100 shares in the last quarter. State Street Corp lifted its holdings in shares of Blue Capital Reinsurance by 10.3% during the 2nd quarter. State Street Corp now owns 108,446 shares of the insurance provider’s stock valued at $1,985,000 after purchasing an additional 10,130 shares in the last quarter. Finally, Bedell Frazier Investment Counseling LLC bought a new position in shares of Blue Capital Reinsurance during the 3rd quarter valued at about $1,522,000. Hedge funds and other institutional investors own 43.53% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was originally reported by Transcript Daily and is owned by of Transcript Daily. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://transcriptdaily.com/2018/01/15/blue-capital-reinsurance-bcrh-upgraded-to-hold-at-zacks-investment-research.html.
About Blue Capital Reinsurance
Blue Capital Reinsurance Holdings Ltd. provides collateralized reinsurance in the property catastrophe market and invests in various insurance-linked securities. The Company conducts its operations through its subsidiaries, including Blue Capital Re Ltd. (Blue Capital Re), which provides collateralized reinsurance, and Blue Capital Re ILS Ltd.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Blue Capital Reinsurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Capital Reinsurance and related companies with MarketBeat.com's FREE daily email newsletter.